Everything below concerns tripeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Glutathione is present in most tissues, with especially high concentrations in the liver. It also serves as a cofactor for some enzymes and helps transport amino acids across cell membranes. In plants and microorganisms, glutathione contributes to stress responses and metal handling. The molecule is synthesized in two ATP-dependent steps, first producing gamma-glutamylcysteine and then adding glycine. Because cysteine availability often limits synthesis, dietary and metabolic factors can influence glutathione levels. Research continues to examine how these levels relate to health and disease.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. The peptide bond between glutamate and cysteine uses the gamma-carboxyl group of glutamate rather than the alpha-carboxyl group. This unusual linkage protects the molecule from many common peptidases. The cysteine side chain carries a thiol group that can undergo reversible oxidation. Because of this thiol, glutathione participates in redox reactions and helps maintain the reducing environment inside most cells in living systems.
Biosynthesis occurs in two ATP-dependent steps. The enzyme glutamate-cysteine ligase joins glutamate and cysteine, forming gamma-glutamylcysteine; glutathione synthetase then adds glycine to produce the complete tripeptide. Because the peptide bond from glutamate uses the gamma-carboxyl group, glutathione resists digestion by many ordinary peptidases. Tissues vary in synthesis capacity, and the liver generally contains high concentrations relative to many other organs. This uneven distribution contributes to organ-specific differences in redox buffering and affects how experimental results are interpreted across tissue types.
Glutathione participates in detoxification reactions, amino acid transport, and the maintenance of protein thiols. It serves as a cofactor for several enzymes, including glutathione peroxidases and glutathione S-transferases. In research literature, altered glutathione status appears in studies of aging, infection, metabolic stress, and environmental exposure. Whether low glutathione is a cause, consequence, or marker of such conditions often remains unresolved. Direct measurement in blood or tissue provides a snapshot, but results depend on sample handling, timing, and the method used.
| Property | Value | Notes |
|---|---|---|
| Common name | Glutathione | Tripeptide of glutamate, cysteine, and glycine |
| Reduced form | GSH | Dominant intracellular thiol |
| Oxidized form | GSSG | Disulfide-linked dimer |
| Molar mass | 307.32 g/mol | For reduced glutathione |
| Functional motif | Gamma-glutamyl-cysteinyl-glycine | Gamma linkage resists many peptidases |
Xing Qiyi (Chinese: 邢其毅; pinyin: Xíng Qíyì; Wade–Giles: Hsing Ch'i-i) was a Chinese organic chemist who contributed to the total synthesis of bovine insulin, Xing is still well-known nowadays in China as the main editor of a highly-influential organic chemistry textbook. He was a member of China Democratic League since 1952.
=== Analgesic === Data from clinical trials have indicated that SNRIs might have pain-relieving properties. Although the perception and transmission of pain stimuli in the central nervous system have not been fully elucidated, extensive data support the roles of serotonin and norepinephrine in pain modulation. Findings from clinical trials in humans have shown that these antidepressants can help to reduce pain and functional impairment in central and neuropathic pain conditions. This property of SNRIs might be used to reduce doses of other pain relieving medication and lower the frequency of safety, limited efficacy, and tolerability issues. Clinical research data has shown that in patients with GAD, duloxetine is significantly more effective than placebo in reducing pain-related symptoms of GAD, after short-term and long-term treatment. However, findings suggested that such symptoms of physical pain recur in relapse situations, which indicate a need for ongoing treatment in patients with GAD and concurrent painful physical symptoms.
Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7), blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.
=== Investment === Investment in dedicated UK AI companies rebounded to £2.9 billion in 2024, surpassing the previous record of £2.4 billion set in 2022 and recovering strongly from a trough of £1.5 billion in 2023. The average deal size rose to approximately £5.9 million in 2024, compared to £4.6 million in 2022. International investors, including Microsoft, Nvidia, and SoftBank, continue to provide the largest investment contributions. In 2024, there were 51 AI-related inward investment projects into the UK, representing over £15 billion in capital investment and expected to create more than 6,500 jobs. These were dominated by infrastructure investments from Amazon, Google, CoreWeave, and Vantage Data Centres. Despite this growth, qualitative research conducted for the Sector Study identified a persistent "scale-up gap": the UK is described as "very good at the start phase, but [at] the scale up phase (beyond Series A), there's a missing piece there". More than half of dedicated AI companies identified in 2024 are at the seed stage of development, showing a healthy start-up scene, but investors cited a lack of larger-scale growth capital, risk aversion among existing UK investors, and insufficient uptake of pension fund investment in venture capital as key structural barriers.
Sources: en.wikipedia.org
== Lawsuits == In November 2010, the parent company of Twin Peaks (Twin Restaurant IP LLC) accused Kevin Laughlin, the owner of Grand Tetons LLC DBA Northern Exposure, of trademark infringement. The lawsuit sought to prevent the opening of Northern Exposure's Fayetteville, Arkansas location after one of Twin Peaks' franchisee noticed a billboard similar to Twin Peaks but advertising Northern Exposure. The lawsuit was settled in the spring of 2011, with Laughlin paying Twin Peaks' legal fees related to the lawsuit. In July 2011, former Hooters executives including CEO and president Coby Brooks, CLO Clay Mingus, Joseph Hummel, Jim Tessmer, Roger Gondek, and the business administrator for the late Robert H. Brooks (founder of Hooters) Patti Frederick left Hooters and formed La Cima Restaurants LLC, a Twin Peaks franchisee. Hooters of America then filed suit against La Cima Restaurants and Joseph Hummel alleging Hummel had electronically sent "more than 500 pages" of Hooters' trade secrets to his private email weeks before he resigned. On May 1, 2012 the Atlanta Business Chronicle reported that Hooters had settled the lawsuit against La Cima and Hummel, with the terms that La Cima and Hummel return or destroy all stolen documents and not use any information on those documents in a competitive manner. On July 8, 2015, the widow of Jesus Delgado Rodriguez (one of the nine bikers killed in the 2015 Waco shootout) filed a lawsuit against Twin Peaks' parent company for negligence.
==== SeV stimulates interferon production and transduction pathway ==== The main component of innate antiviral response is type I interferons (IFNs) production and most cells can produce type I IFNs, including IFN-α and -β. The recognition by cellular molecules that are called pattern recognition receptors (PRR) of triggering viral elements, such as the virus genomic RNA, the replication intermediary double-stranded RNA, or the viral ribonucleoproteins, promotes IFN production and response pathways. Viral genomic and protein components can bind variable PRRs and stimulate a signaling pathway that results in the activation of the transcription factors, which relocate to nucleus and trigger type I IFNs transcription.
==== Pollybeak ==== The "pollybeak" deformity, characterized by excessive supratip fullness usually involving a cartilaginous hump or loss of tip projection, is the indication for approximately 50% of all revision rhinoplasties. If too much of the osseo-cartilaginous framework is removed, the consequent weakening can cause the external nasal skin to become shapeless, resulting in a "pollybeak" deformity, resembling the beak of a parrot.
The two substrates of this enzyme are dihydrophloroglucinol (1) and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are phloroglucinol (2), reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is dihydrophloroglucinol:NADP+ oxidoreductase. This enzyme participates in benzoate degradation via CoA ligation.
2 NaN3 + 2 HNO2 → 3 N2 + 2 NO + 2 NaOH A safer modification to the above method that avoids the potential production of hydrazoic acid or nitrogen oxide fumes is that of W. F. Rinkenbach. A solution of 2.5 oz (71 g) sodium nitrite in 1 US pt (470 mL) of water is added to a stirring dispersion of 1 oz (28 g) sodium azide in 1.5 US gal (5.7 L) 10% ammonium acetate, followed by addition of 7 US fl oz (210 mL) of glacial acetic acid. The solution is allowed to stand in a warm place for an hour and disposed of.
Sources: en.wikipedia.org
But in the Psychedelics Encyclopedia, author Peter Stafford writes: "The psilocybin experience seems to be warmer, not as forceful and less isolating. It tends to build connections between people, who are generally much more in communication than when they use LSD."
Crystallization of ubiquitin protein was successfully done using racemic crystallography. Crystallization of either D-ubiquitin or L-ubiquitin alone is difficult, whereas a racemic mixture of D-ubiquitin and L-ubiquitin was readily crystallized and diffraction quality crystals were obtained overnight in almost half the conditions tested in a standard commercial crystallization screen. Crystallization of racemates of disulfide-containing microprotein molecules was used to determine the structure of trypsin inhibitor SFTI-1 (14 amino acids,1 disulfide), conotoxin cVc1.1 (22 amino acids, 2 disul-fides) and cyclotide kB1 (29 amino acids, 3 disulfides). Using X-ray diffraction, it was found that the racemates crystallized in the centrosymmetric spacegroups P3(bar), Pbca and P1(bar). Interestingly, achiral "'peptoid'" chains were found to fold as racemic pairs and crystallize in highly preferred centrosymmetric space groups. A high-resolution crystal structure of the racemate of a heterochiral D-protein complex with vascular endothelial growth factor A (VEGF-A). The mirror image D-protein form of VEGF-A was used in phage display to identify a 56 residue L-protein binder with nanomolar affinity; the chemically synthesized D-protein binder had the same affinity for the L-protein form of VEGF-A. A mixture of chemically synthesized proteins consisting of D-VEGF-A, L-VEGF-A, and two equivalents each of the D-protein binder and L-protein binder, gave racemic crystals in the centrosymmetric space group P21/n.
Version 1.4a was published in February 2015; the underlying DisplayPort version was updated to 1.3 in order to support HBR3 data rates, Display Stream Compression 1.1, Segmented Panel Displays, and partial updates for Panel Self-Refresh. Version 1.4b was published in October 2015; its protocol refinements and clarifications are intended to enable adoption of eDP 1.4b in devices by mid-2016. Version 1.5 was published in October 2021; adds new features and protocols, including enhanced support for Adaptive-Sync, that provide additional power savings and improved gaming and media playback performance.
=== Influenza === Flublok Quadrivalent is a licensed recombinant subunit vaccine for active immunisation against influenza. It contains HA proteins of four strains of influenza virus purified and extracted using the Baculovirus-insect expression system. The four viral strains are standardised annually according to United States Public Health Services (USPHS) requirements. Flublok Quadrivalent has a comparable safety profile to traditional trivalent and quadrivalent vaccine equivalents. Flublok is also associated with less local reactions (RR = 0.94, 95% CI 0.90–0.98, three RCTs, FEM, I2 = 0%, low‐ certainty evidence) and higher risk of chills (RR = 1.33, 95% CI 1.03–1.72, three RCTs, FEM, I2 = 14%, low‐certainty evidence).
Sources: en.wikipedia.org
Glutathione is a tripeptide made from glutamate, cysteine, and glycine. Its cysteine residue provides a thiol group that is central to its redox activity. The glutamate-cysteine bond forms through the gamma-carboxyl group of glutamate.
Reduced glutathione, GSH, can donate electrons and become oxidized to GSSG. The balance between these forms reflects the cell's redox environment. A shift toward GSSG is commonly interpreted as evidence of oxidative stress, though the ratio can vary by tissue and method.
Glutathione occurs in nearly all cell types, with notable amounts in the liver. It is also present in the lungs, kidneys, and red blood cells. Concentrations differ among tissues and change with age, diet, and disease states.
GSH is the reduced form of glutathione, with a free thiol group on cysteine. GSSG is the oxidized disulfide form, created when two GSH molecules become linked. The two forms exist together, and their balance is often reported as the GSH/GSSG ratio in laboratory studies.